任瑞宝教授先后获得北京大学健康科学中心医学博士学位和纽约哥伦比亚大学外科医师学院博士学位。而后他在洛克菲勒大学诺贝尔奖得主戴维·巴尔的摩的实验室里接受博士后培训。1994年加入布兰代斯大学生物系，2008年晋升为终身教授。2011年加入上海交通大学医学院附属瑞金医院上海血液病研究所。他的实验室已经为人类白血病创建了许多小鼠模型，并利用分子和化学生物学方法发现和开发新的癌症靶向治疗方法。任教授在Cell, Nature, Science等高质量期刊上发表同行评议研究论文85篇，被引用8500余篇。他还担任Hematology and Oncology副主编、Aging and Cancer副主编和Frontiers of Medicine编辑委员会成员。
Prof. Ruibao Ren received his M.D. from the Peking University Health Sciences Center and Ph.D. from the College of Physicians and Surgeons, Columbia University, New York. He did his postdoctoral training in the laboratory of Nobel Laureate David Baltimore at The Rockefeller University. He joined the faculty of the Department of Biology, Brandeis University in 1994 and was promoted to the rank of tenured professor in 2008. He joined the Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine in 2011. His laboratory has generated a number of mouse models for human leukemia and used molecular and chemical biology approaches to discover and develop novel targeted therapies for cancer. He has published 85 peer reviewed research articles in high quality journals including Cell, Nature, Science and Blood, with citations more than 8500. He has received Junior Faculty Awards from American Cancer Society and March of Dimes, Basil O’Connor as well as the Leukemia and Lymphoma Society Scholar Award. He also serves as an associate editor of the Journal of Hematology and Oncology, associated editor of Aging and Cancer and editorial board member of Frontiers of Medicine.